LICPX | VTIAX | LICPX / VTIAX | |
Total Expense Ratio | 1.17 | 0.09 | 1,300% |
Annual Report Gross Expense Ratio | 1.17 | 0.09 | 1,300% |
Fund Existence | 21 years | 15 years | - |
Gain YTD | 19.529 | 15.244 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 404M | 493B | 0% |
Annual Yield % from dividends | 1.07 | 2.88 | 37% |
Returns for 1 year | 13.43 | 12.69 | 106% |
Returns for 3 years | 44.16 | 34.11 | 129% |
Returns for 5 years | 45.30 | 44.24 | 102% |
Returns for 10 years | 43.12 | 44.64 | 97% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSCX | 49.45 | N/A | N/A |
BlackRock Health Sciences Opps Inv C | |||
BRGAX | 38.48 | N/A | N/A |
iShares Russell 1000 Large-Cap Idx Inv A | |||
ANVRX | 10.06 | N/A | N/A |
American Century Non-US Intrs Val R | |||
BRZKX | 13.21 | N/A | N/A |
BlackRock Sus Adg Intl Eq K | |||
WIISX | 14.20 | -0.17 | -1.18% |
William Blair International Sm Cap Gr R6 |